Search
for
Sort by
Research 121–150 of 153
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- An Animal Model of Trichloroethylene-Induced Skin Sensitization in BALB/c Mice
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Limitations of Treatment-Induced Alopecia Grading Instruments in Evaluating Therapeutic Response
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Present Chemotherapy Induced Alopecia and Research in Future
- Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Treatment Outcomes of Triamcinolone Acetonide Compared with Cryotherapy in Alopecia Areata: Evidence from a Systematic Review and Meta-Analysis
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia
- Mutational spectrum in 101 patients with hypohidrotic ectodermal dysplasia and breakpoint mapping in independent cases of rare genomic rearrangements
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
- Gender-specific side effects of chemotherapy in pancreatic cancer patients
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo
- Combination of All-Trans Retinoic Acid Resumes the Sustained Response of TPO-RA in ITP
- Principles of chemotherapy
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Management of Alopecia Due to Cancer Therapies
- Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial